There is certainly an argument that, if the Fed is worried about inflation, it shouldnt wait to act, and the market is currently placing roughly 1-in-3 chance that the Fed hikes rates on July 29 th
Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027
2.5mg is not a therapeutic effect but is necessary for the first 4 weeks
The value proposition of the KLOW Blend is substantial: purchasing these four peptides individually would cost significantly more than the combined formulation, while the co-lyophilization ensures precise ratios and eliminates the variability inherent in manual reconstitution and mixing of separate vials
Primary endpoints included adverse events, SARS-CoV-2 infection incidence in Cohort 1, and disease progressions in Cohort 2
Risk of suicidal ideation and self-injury